Yudong Quan
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Antimalarial drugs and their metabolites are potent Zika virus inhibitors.
Journal: Journal of medical virology
Published: October 29, 2018
Erratum for Mesplède et al., "The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration".
Journal: mBio
Published: September 27, 2018
The antimalarial drug amodiaquine possesses anti-ZIKA virus activities.
Journal: Journal of medical virology
Published: August 21, 2017
JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1.
Journal: Journal of virology
Published: January 13, 2017
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
Journal: The Journal of antimicrobial chemotherapy
Published: September 27, 2016
Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay.
Journal: Journal of medical virology
Published: August 08, 2016
Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.
Journal: Antiviral chemistry & chemotherapy
Published: July 08, 2015
A resveratrol analog termed 3,3',4,4',5,5'-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor.
Journal: Journal of medical virology
Published: May 12, 2015
Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines.
Journal: Virology journal
Published: August 20, 2014
The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity.
Journal: Journal of virology
Published: November 15, 2013
Last Updated: 09/26/2026